Clinitech Laboratory Ltd Financial Ratios
CTLLAB · Healthcare Services · Current price ₹32
P/E ratio
17.5x
P/B ratio
0.8x
ROE
4.5%
ROCE
6.8%
Debt / Equity
0.06
Dividend yield
—
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 17.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 4.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 6.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.06 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Clinitech Laboratory Ltd's latest numbers.
Clinitech Laboratory Ltd profitability
Clinitech Laboratory Ltd generates a return on equity of 4.5% and a return on capital employed of 6.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.06 and a P/E of 17.5x, Clinitech Laboratory Ltd is conservatively financed. Our overall business-quality score for the company is 4.0 / 10.
Understand the ratios
More on Clinitech Laboratory Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.